{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "21446933", "DateCompleted": {"Year": "2012", "Month": "01", "Day": "02"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1111/j.1365-2125.2011.03974.x"], "ArticleDate": [], "Journal": {"ISSN": "1365-2125", "JournalIssue": {"Volume": "72", "Issue": "2", "PubDate": {"Year": "2011", "Month": "Aug"}}, "Title": "British journal of clinical pharmacology", "ISOAbbreviation": "Br J Clin Pharmacol"}, "ArticleTitle": "Important details to be clarified about the effect of rectal ozone on the portal vein oxygenation.", "Pagination": {"StartPage": "350", "EndPage": "352", "MedlinePgn": "350-1; author reply 352"}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Bocci", "ForeName": "Velio", "Initials": "V"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zanardi", "ForeName": "Iacopo", "Initials": "I"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Travagli", "ForeName": "Valter", "Initials": "V"}], "PublicationTypeList": ["Letter", "Comment"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Br J Clin Pharmacol", "NlmUniqueID": "7503323", "ISSNLinking": "0306-5251"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Vasodilator Agents"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "9Y8NXQ24VQ", "NameOfSubstance": "Propranolol"}], "CommentsCorrectionsList": [{"RefSource": "Br J Clin Pharmacol. 2011 Mar;71(3):411-5. doi: 10.1111/j.1365-2125.2010.03851.x", "PMID": "21284700"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Hypertension, Portal"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Liver Cirrhosis"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Ozone"}, {"QualifierName": ["drug effects"], "DescriptorName": "Portal Vein"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Propranolol"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Vasodilator Agents"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Zaky S, Kotb H, Fouad E. The effect of rectal ozone on the portal vein oxygenation and pharmacokinetics of propranolol in liver cirrhosis (a preliminary human study) Br J Clin Pharmacol. 2011;71:411\u20135.", "ArticleIdList": ["PMC3045550", "21284700"]}, {"Citation": "Bocci V, Borrelli E, Corradeschi F, Valacchi G. Systemic effects after colorectal insufflation of oxygen/ozone in rabbit. Int J Med Biol Environ. 2000;28:109\u201313."}, {"Citation": "Bocci V. Ozone. A New Medical Drug. 2nd edn. Dordrecht, The Netherlands: Springer; 2011."}, {"Citation": "Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev. 2009;29:646\u201382.", "ArticleIdList": ["19260079"]}]}], "History": [{"Year": "2011", "Month": "3", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "3", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "1", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "8", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["21446933", "PMC3162664", "10.1111/j.1365-2125.2011.03974.x"]}}], "PubmedBookArticle": []}